LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,093
تعداد مقالات10,023
تعداد مشاهده مقاله27,233,381
تعداد دریافت فایل اصل مقاله7,479,992
Taghvaei-Bijandi, Elnaz, Abedian, Fatemeh, Ahmadzadeh Amiri, Ahmad, Jafari, Narjes, Abediankenari, Saeid. (1402). The Upregulation of HLA-G1 and miRNA-34a in Lens Epithelial Cells of Diabetic Retinopathy Patients. سامانه مدیریت نشریات علمی, 20(2), 202-210. doi: 10.22034/iji.2023.97403.2510
Elnaz Taghvaei-Bijandi; Fatemeh Abedian; Ahmad Ahmadzadeh Amiri; Narjes Jafari; Saeid Abediankenari. "The Upregulation of HLA-G1 and miRNA-34a in Lens Epithelial Cells of Diabetic Retinopathy Patients". سامانه مدیریت نشریات علمی, 20, 2, 1402, 202-210. doi: 10.22034/iji.2023.97403.2510
Taghvaei-Bijandi, Elnaz, Abedian, Fatemeh, Ahmadzadeh Amiri, Ahmad, Jafari, Narjes, Abediankenari, Saeid. (1402). 'The Upregulation of HLA-G1 and miRNA-34a in Lens Epithelial Cells of Diabetic Retinopathy Patients', سامانه مدیریت نشریات علمی, 20(2), pp. 202-210. doi: 10.22034/iji.2023.97403.2510
Taghvaei-Bijandi, Elnaz, Abedian, Fatemeh, Ahmadzadeh Amiri, Ahmad, Jafari, Narjes, Abediankenari, Saeid. The Upregulation of HLA-G1 and miRNA-34a in Lens Epithelial Cells of Diabetic Retinopathy Patients. سامانه مدیریت نشریات علمی, 1402; 20(2): 202-210. doi: 10.22034/iji.2023.97403.2510

The Upregulation of HLA-G1 and miRNA-34a in Lens Epithelial Cells of Diabetic Retinopathy Patients

Iranian Journal of Immunology
مقاله 6، دوره 20، شماره 2، شهریور 2023، صفحه 202-210    اصل مقاله (798.02 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22034/iji.2023.97403.2510
نویسندگان
Elnaz Taghvaei-Bijandi1؛ Fatemeh Abedian1؛ Ahmad Ahmadzadeh Amiri2؛ Narjes Jafari1؛ Saeid Abediankenari* 1
1Immunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
2Department of Ophthalmology, Mazandaran University of Medical Sciences, Sari, Iran.
چکیده
Background: Retinopathy of diabetes is a chronic diabetes mellitus complication affecting retinal vessels, and some ocular complications’ molecular mechanisms remain obscure.
Objective: To evaluate the expression of HLA-G1, HLA-G5, miRNA-181a, and miRNA-34a in the lens epithelial cells of patients with retinopathy of diabetes.
Methods: In a case-control study, 30 diabetic patients with retinopathy, 30 diabetic patients without retinopathy, and 30 cataract patients without diabetes mellitus as the control group were enrolled after a full description with details about the study methods and objectives. The expression of HLA G1, HLA G5, miRNA-181a, and miRNA-34a in lens epithelial cells was assessed by quantitative RT PCR. Moreover, the levels of HLA-G protein in aqueous humor were evaluated by the ELISA method.
Results: HLA-G1 expression was significantly upregulated in the retinopathy group (P=0.003). The aqueous humor of diabetic retinopathy patients contained significantly higher levels of HLA-G protein compared with the non-diabetic patients (P=0.001). miRNA-181a was significantly downregulated in the diabetic retinopathy group compared with the patients without diabetes (P=0.001). In addition, miRNA-34a was upregulated in the retinopathy group (P=0.009).
Conclusion: Taken together, the present results showed that HLA-G1 and miRNA-34a can be valuable markers for diabetic retinopathy. Our data offers new perspectives for improving the control of inflammation in the lens epithelial cells by considering HLA-G and miRNA.
کلیدواژه‌ها
Diabetic Retinopathy؛ HLA-G؛ Lens Epithelial Cells؛ miRNA-181a؛ miRNA34a
مراجع
  1. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322-1335
  2. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes care. 2004; 27:s84-s87
  3. Beltramo E, Porta M. Pericyte loss in diabetic retinopathy mechanisms and consequences. Curr Med Chem. 2013;20:3218-3225
  4. Jafari N, Abediankenari S MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell. Tumor Biol. 2017; 39:1010428317701652.
  5. Dong N, Tang X, Xu B. miRNA-181a Inhibits the Proliferation, Migration, and Epithelial–Mesenchymal Transition of Lens Epithelial CellsmiRNA-181a in the Treatment of PCO. Invest Ophthalmol Vis Sci. 2015;56:993-1001.
  6. Fons P, Chabot S, Cartwright JE, Lenfant F, L'Faqihi F, Giustiniani J, et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood. 2006; 108:2608-2615.
  7. Svendsen SG, Udsen MS, Daouya M, Funck T, Wu C-L, Carosella ED, et al. Expression and differential regulation of HLA-G isoforms in the retinal pigment epithelial cell line, ARPE-19. Hum Immunol. 2017; 78:414-420.
  8. Carosella ED, Favier B, Rouas-Freiss N, Moreau P, LeMaoult J, et al. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood. 2008;111:4862-4870.
  9. Saeideh Sadat Shobeiri , Zahra Rahmani   , Hadi Hossein Nataj , Hossein Ranjbaran , Masoud Mohammadi  , Saeid Abediankenari.Uterine Natural Killer Cell and Human Leukocyte Antigen-G1 and Human Leukocyte Antigen-G5 Expression in Vaginal Discharge of Threatened-Abortion Women: A Case-Control Study. J Immunol Res. 2015; 2015:692198
  10. Porto IO, Mendes-Junior CT, Felício LP, Georg RC, Moreau P, Donadi EA, et al. MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G. Mol Immunol. 2015 ;65:230-241.
  11. Chen Q, Luo G, Zhang X. MiR‑148a modulates HLA‑G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine. 2017;14:4448-4452.
  12. Abediankenari S, Eslami MB, Sarrafnejad A, Mohseni M, Larijani B. Dendritic cells bearing HLA-G inhibit T-Cell activation in type 1 diabetes.Iran J Allergy Asthma Immunol. 2007;6(1):1-7.
  13. McGEER PL, McGEER EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. 2004;1035:104-116.
  14. Bandello F, Lattanzio R, Zucchiatti I, Del Turco C. pathophysiology  and treatment of diabetic retinopathy.Acta Diabetol. 2013;50(1):1-20.
  15. Le Discorde M, Moreau P, Sabatier P, et al. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum immunol. 2003; 64:1039-1044.
  16. Rizzo R, Bortolotti D, Bolzani S, Fainardi E. HLA-G molecules in autoimmune diseases and infections. Front immunol. 2014;5:592.
  17. Yan W-H, Lin A, Chen B-G, Chen S-Y. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis. 2009;200:820-826.
  18. Feng S, Yu H, Yu Y, Geng Y, Li D, Yang C, et al. Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy. J Diabetes Res. 2018; 4:8546423.
  19. Yan D, Da Dong X, Chen X, Yao S, Wang L, Wang J, et al. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PloS one. 2012;7:e40967.
  20. Ma J, Wang J, Liu Y, Wang C, Duan D, Lu N, et al. Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus. Clinics. 2017;72:111-115.
  21. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta diabetol. 2011;48:61-69.
  22. Xiong F, Du X, Hu J, Li T, Du S, Wu Q. Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis. Curr Eye Res. 2014; 39:720-729.
  23. Ramzan F, D'Souza RF, Durainayagam BR, Milan AM, Markworth JF, Miranda-Soberanis V, Sequeira IR, Roy NC, Poppitt SD, Mitchell CJ, Cameron-Smith D. Circulatory miRNA biomarkers of metabolic syndrome. Acta Diabetol. 2019; 21. doi: 10.1007/s00592-019-01406-6.
  24. Zhu X-m, Han T, Wang X-h, Li Y-h, Yang H-g, Luo Y-n, et al. Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. Am J Obstet Gynecol. 2010;202:592 e1-592 e7.
  25. Ragab HM, Ezzat WM, Hassan EM, El Maksoud NA, Afify M, Abd El-Maksoud MDE, Elaziz WA. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease. J Genet Eng Biotechnol. 2023;21(1).
  26. Kumar V, Pandey A, Arora A, Gautam P, Bisht D, Gupta S, Chaurasia A, Sachan M. Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis. DNA Cell Biol. 2023 Feb 13. doi: 10.1089/dna.2022.0487.
آمار
تعداد مشاهده مقاله: 710
تعداد دریافت فایل اصل مقاله: 477


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب